ALS

ALS Awareness Month – June

Published: 2Jun2015

As a major Canadian centre for amyotrophic lateral sclerosis (ALS) research and treatment, the Montreal Neurological Institute and Hospital - The Neuro, invites the public and the media to learn...

ALS Awareness Month – June 2016

Published: 13Jun2016

The Neuro is recognized as a major Canadian center for ALS research and patient care. During June, designated ALS Month, The Neuro redoubles its efforts to inform the public and the media about...

ALS – Fostering awareness of a devastating disease

Published: 2Jun2017

ALS takes away the patient’s motor functions one at a time, and the progress of finding effective drugs to counter its insidious effects has been slow. June is ALS Month, a good time to update the...

The MNI forms promising Open Science partnership with Takeda

Published: 4Dec2017

Industry and academia team up for the benefit of people suffering from ALS...

The Neuro and Thermo Fisher Scientific Partner to Fight Neurodegenerative Disease

Published: 5Mar2018

Industry and academia to share expertise in effort to develop improved methods to produce and characterize antibodies and reagents for neurological research

Major ALS Research Funding Announced

Published: 23Nov2016

MNI scientists will study stem cells, genetic mutations to develop new treatments...

Three Neuro researchers receive ALS Canada funding

13 Nov 2019

Stefano Stifani, Patrick Dion, and Rahul Kumar will study genetics and cell types involved with ALS

Opinion: scientists need to demand better antibody validation

22 Oct 2019

My lab has developed a protocol to easily assess the specificity of antibodies—and hopefully stem some of the reproducibility crisis

Pages

The Neuro logo McGill logoMcGill University Health Centre logoKillam logo

The Neuro is a McGill research and teaching institute; delivering the highest quality patient care, as part of the Neuroscience Mission of the McGill University Health Centre. We are proud to be a Killam Institution, supported by the Killam Trusts.